NIH-funded research R01 grant

Anal transition zone cells that repair the colon lining

Official title: Colonic epithelial wound healing by anal transitional cells

Funded at University of Chicago · NIH-11325804 · Data updated 2026-11-12

Seeing if special cells near the anus can help heal the damaged colon lining for people with inflammatory bowel disease.

More Wound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$564,004
NIH project number5R01DK135954-04
Project IDNIH-11325804 on NIH RePORTER

Who could benefit from this research

Could help

People with inflammatory bowel disease affecting the colon—especially ulcerative colitis or colonic Crohn's with ongoing mucosal injury—would be the most relevant candidates for related future trials or sample donation.

Less likely to help

People whose disease is limited to the small intestine, who do not have colonic mucosal injury, or whose condition is not IBD are less likely to benefit from these findings.

What this research studies

This project follows a tiny band of 'skin-like' cells at the anal transition zone (ATZ) that can move into an injured colon and form a new lining called squamous neo-epithelium of colon (SNEC). Researchers use lab models of colitis, cell tracing, and molecular analyses to watch how those ATZ cells survive inflammation, migrate, and rebuild the epithelial barrier. They compare these cells to normal colon cells to find the genes and signals that allow ATZ cells to resist damage and promote repair. The team aims to identify pathways that could be targeted by future treatments to speed mucosal healing in people with IBD.

Why it matters

Potential benefit: If successful, this work could point to new ways to help the bowel lining heal faster and more completely in inflammatory bowel disease, potentially reducing flares and the need for surgery.

How similar studies have gone: Early animal studies have shown ATZ cells can generate a new colon-like lining in mice, but translating this into human therapies is novel and untested.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Liu, Cambrian Yangshao — University of Chicago
  • Study coordinator: Liu, Cambrian Yangshao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.